Mutation Frequencies in HIV-1 Genome in Regions Containing Efficient RNAi Targets As Calculated from Ultra-Deep Sequencing Data
HIV-1 is one of the most variable viruses. The development of gene therapy technology using RNAi for AIDS/HIV-1 treatment is a potential alternative for traditional anti-retroviral therapy. Anti-HIV-1 siRNA should aim to exploit the most conserved viral targets. Using the deep sequencing of potential RNAi targets in 100-nt HIV-1 genome fragments from the clinical HIV-1 subtype A isolates in Russia, we found that the frequencies of all possible transversions and transitions in certain RNAi targets are 3–38 times lower than in adjacent sequences. Therefore, these targets are conserved. We propose the development of these RNAi targets for AIDS/HIV-1 treatment. Deep sequencing also enables the detection of the characteristic mutational bias of RT during the replication of viral RNA.
Keywordsgene therapy HIV-1 RNAi mutations RT transversions transitions gene therapy deep sequencing
human immune deficiency virus type 1
100-bp HIV-1 genome fragments with effective RNAi targets
enhancer protein of viral particle release
protein that facilitates HIV entry into a host cell
Unable to display preview. Download preview PDF.
- 6.Andrews S. 2010. FastQC: A quality control tool for high throughput sequence data. http://www.bioinformatics. babraham.ac.uk/projects/fastqc.Google Scholar
- 11.Kravatsky Y.V., Chechetkin V.R., Fedoseeva D.M., et al. 2017. A bioinformatic pipeline for monitoring of the mutational stability of viral drug targets with deepsequencing technology. Viruses. 9, pii: E357. doi 10.3390/v9120357Google Scholar
- 13.Johnson N.L., Leone F.C. 1977. Statistics and Experimental Design in Engineering and the Physical Sciences. New York: Wiley.Google Scholar
- 14.Pathak V.K., Temin H.M. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. U. S. A. 87, 6019–6023.CrossRefPubMedPubMedCentralGoogle Scholar